Seeking Alpha

ISIS Pharmaceuticals (ISIS -1.8%) and Genzyme (SNY) say the Committee for Medicinal Products for...

ISIS Pharmaceuticals (ISIS -1.8%) and Genzyme (SNY) say the Committee for Medicinal Products for Human Use adopted a negative opinion for its marketing authorization of the cholesterol drug Kynamro, a setback for the treatment.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|